Lagura, Wilhelmina B.

HRN: 27-82-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/24/2025
10/01/2025
IV
2.25mg
Q6
CAP Non Resolve
Checking Initial Appropriateness 

 Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines